Objective: To determine the isoelectric points of polypeptide, insulin, fusion protein vaccine and HPV virus-like particle(VLPs) by whole column imaging detection-capillary isoelectric focusing(WCIDCIEF). Methods: Cartridges of 50 mm×100 μm i. d. internally fluorocarbon-coated fused-silica capillary was used with the following settings:pre-focusing for 1 min under 1. 5 kV,followed by focusing at 3 kV for 4 min or 8 min;detection wavelength:280 nm. Results: The isoelectric points (pI) of the polypeptide,the hormone sample (insulin) and the fusion protein vaccine were 10. 98, 5. 87 and 5. 86, respectively. The five virus-like particles displayed pI values of 8. 17(HPV 31L1),7. 86(HPV 33L1),7. 77(HPV 45L1),7. 91(HPV 52L1) and 7. 69 (HPV 58L1). The obtained pI values were substantially consistent with the theoretical pI values. The specificity and precision of WCID-CIEF were validated. Conclusion: The method can be used for determing the isoelectric point of biological products.
[1] WU XZ, HUANG TM, ZHEN L, et al. Whole-column imagingdetection techniques and their analytical applications[J]. Trends Anal Chem,2005, 24(5):369
[2] WU JQ, LI SC, ARTHUR W. Optimizing separation conditions for proteins and peptides using imaged capillary isoelectric focusing[J]. J Chromatogr A,1998, 817(1-2):163
[3] LAWRENCE G, CAROLYN G, WU JQ, et al. Isoelectric point determination of norovirus virus-like particles by capillary isoelectric focusing with whole column imaging detection[J]. Anal Chem, 2004, 76(1):48
[4] ZHOU CM. Characterization of human papillomavirus by capillary isoelectric focusing with whole-column imaging detection[J]. Electrophoresis,2013, 34(20-21):3046
[5] ZHOU CM, ZHANG GX, MA XX. Characterization and evaluation of the immune responses elicited by a novel human papillomavirus (HPV)therapeutic vaccine[J]. J Virol Methods,2014, 197(1):1
[6] 周朝明.毛细管电泳法测定重组人乳头瘤病毒原液的纯度[J]. 药物分析杂志,2012, 33(12):2118 ZHOU CM. Capillary electrophoresis purity determination of recombinant human papillomavirus(HPV)bulk[J]. Chin J Pharm Anal 2012, 33(12):2118
[7] 周朝明,马新兴,周婧怡,等.重组人乳头瘤病毒双价(16/18型)疫苗免疫原性评价方法的研究[J].药物分析杂志,2011, 31(9):1743 ZHOU CM,MA XX,ZHOU JY,et al. Study on recombinant human papillomavirus(16/18)vaccine immunogenicity evaluation assay[J]. Chin J Pharm Anal,2011, 31(9):1743
[8] 周朝明. Biacore法测定重组人乳头瘤病毒双价(16/18型)疫苗原液的动力学常数[J].药物分析杂志, 2014, 34(2):215 ZHOU CM. Determination of the kinetic constants of recombinant human papillomavirus(HPV)bivalent(types 16 and 18)vaccine bulks by Biacore[J]. Chin J Pharm Anal,2014, 34(2):215
[9] 周朝明,陈露,马文艺.利用假病毒法检测重组人乳头瘤病毒双价(1618型)疫苗的免疫原性[J].免疫学杂志, 2014, 30(8):731 ZHOU CM, CHEN L, MA WY. Detection of the immunogenicity of recombinant human papillomavirus(HPV)bivalent(types 16 and 18)vaccine by pseudovirus assay[J]. Immunol J, 2014, 30(8):731
[10] LAWRENCE G, CAROLYN G, WU JQ, et al. Isoelectric point determination of norovirus virus-like particles by capillary isoelectric focusing with whole column imaging detection[J]. Anal Chem, 2004, 76(1):48
[11] ZHEN L, WU SS, JANUSZ P. Characterization of plant growthpromoting rhizobacteria using capillary isoelectric focusing with whole column imaging detection[J]. J Chromatogr A, 2007, 1140(1-2):213
[12] TAO B, JANUSZ P. Characterization of bovine serum albumintryptophan interaction by capillary isoelectric focusing with whole column imaging detection[J]. J Chromatogr A,2006,1105(1-2):25
[13] TAO B, JANUSZ P. Characterization of phospholipid-protein interactions by capillary isoelectric focusing with whole-column imaging detection[J]. Anal Biochem,2006, 350(1):91
[14] WU XZ, HUANG TM, LIU Z, et al. Whole-column imagingdetection techniques and their analytical applications[J]. Trends Anal Chem,2005, 24(5):369
[15] 于传飞,郭玮,王兰,等.成像毛细管等电聚焦电泳法对单克隆抗体制品的电荷异质性分析[J].药物分析杂志, 2014, 34(7):1212 YU CF, GUO W, WANG L, et al. Charge heterogeneity analysis of monoclonal antibody products with imaging capillary isoelectric focusing electrophoresis[J]. Chin J Pharm Anal, 2014, 34(7):1212
[16] LIN J,TAN QQ,WANG SX. A high-resolution capillary isoelectric focusing method for the determination of therapeutic recombinant monoclonal antibody[J]. J Sep Sci,2011, 34(14):1696